Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe

Background While treat-to-target (T2T) is endorsed for the management of rheumatoid arthritis (RA), data on the degree of implementation in clinical practice are limited. This study investigated the use of T2T for RA in a real-world setting across Europe.Methods The Adelphi RA Disease-Specific Progr...

Full description

Bibliographic Details
Main Authors: Bruno Fautrel, Rieke Alten, Yves Piette, Roberto Caporali, Susana Romero-Yuste, Jasper Broen, Katrien Van Beneden, Martin Welcker, Peter C. Taylor, Oliver Howell, Elke Rottier, Monia Zignani
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002658.full
_version_ 1797788537201885184
author Bruno Fautrel
Rieke Alten
Yves Piette
Roberto Caporali
Susana Romero-Yuste
Jasper Broen
Katrien Van Beneden
Martin Welcker
Peter C. Taylor
Oliver Howell
Elke Rottier
Monia Zignani
author_facet Bruno Fautrel
Rieke Alten
Yves Piette
Roberto Caporali
Susana Romero-Yuste
Jasper Broen
Katrien Van Beneden
Martin Welcker
Peter C. Taylor
Oliver Howell
Elke Rottier
Monia Zignani
author_sort Bruno Fautrel
collection DOAJ
description Background While treat-to-target (T2T) is endorsed for the management of rheumatoid arthritis (RA), data on the degree of implementation in clinical practice are limited. This study investigated the use of T2T for RA in a real-world setting across Europe.Methods The Adelphi RA Disease-Specific Programme was a point-in-time survey of rheumatologists and their consulting patients with RA conducted between January and October 2020 in Belgium, France, Germany, Italy, Spain and the UK. Rheumatologists completed an attitudinal survey, and a record form for their next 10–12 consulting patients, who were invited to voluntarily complete a patient-reported questionnaire. Data collected included clinical characteristics, treatment patterns and attitudes towards T2T.Results Overall, 316 rheumatologists provided data for 3120 patients, of whom 1108 completed the questionnaire. While 86.1% of rheumatologists estimated using T2T principles in clinical practice, only 66.6% of patients were reported by their physician to be managed using a T2T approach. Achieving disease remission was the most commonly reported treatment goal identified by rheumatologists (79.7%), followed by symptom control (47.8%) and reducing impact on quality of life (44.5%). 40.8% of rheumatologists and their patients were in agreement that a treatment goal had been set. When there was agreement on treatment goals, we observed better patient satisfaction, engagement and treatment success.Conclusions Despite recommendations, the T2T approach in RA appears to be suboptimally implemented in clinical practice. This highlights the importance of patient-centricity in the decision-making process to define meaningful targets and select appropriate treatments to improve disease outcomes.
first_indexed 2024-03-13T01:36:59Z
format Article
id doaj.art-822b21dea1ea4f8f9e6bb9c678a2f607
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-03-13T01:36:59Z
publishDate 2022-12-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-822b21dea1ea4f8f9e6bb9c678a2f6072023-07-04T03:00:07ZengBMJ Publishing GroupRMD Open2056-59332022-12-018210.1136/rmdopen-2022-002658Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in EuropeBruno Fautrel0Rieke Alten1Yves Piette2Roberto Caporali3Susana Romero-Yuste4Jasper Broen5Katrien Van Beneden6Martin Welcker7Peter C. Taylor8Oliver Howell9Elke Rottier10Monia Zignani1113 Rheumatology, Pitié-Salpêtrière hospital, AP - HP, Paris, FranceInternal Medicine, Rheumatology, Schlosspark-Klinik GmbH, Berlin, GermanyDepartment of Rheumatology, Ghent University Hospital, Ghent and AZ Sint-Jan Brugge - Oostende AV, Bruges, BelgiumDivision of Clinical Rheumatology, ASST Gaetano Pini, Milano, ItalyDepartment of Rheumatology, University Hospital Complex of Pontevedra, Pontevedra, SpainRegional Rheumatology Center, Maxima Medical Centre, Eindhoven, The NetherlandsMedical Affairs, Galapagos, NV, Mechelen, BelgiumMVZ für Rheumatologie, Dr. M. Welcker, Planegg, GermanyBotnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UKAutoimmune Franchise, Adelphi Real World, Bollington, UKAutoimmune Franchise, Adelphi Real World, Bollington, UKEvidence Generation, Galapagos NV, Mechelen, BelgiumBackground While treat-to-target (T2T) is endorsed for the management of rheumatoid arthritis (RA), data on the degree of implementation in clinical practice are limited. This study investigated the use of T2T for RA in a real-world setting across Europe.Methods The Adelphi RA Disease-Specific Programme was a point-in-time survey of rheumatologists and their consulting patients with RA conducted between January and October 2020 in Belgium, France, Germany, Italy, Spain and the UK. Rheumatologists completed an attitudinal survey, and a record form for their next 10–12 consulting patients, who were invited to voluntarily complete a patient-reported questionnaire. Data collected included clinical characteristics, treatment patterns and attitudes towards T2T.Results Overall, 316 rheumatologists provided data for 3120 patients, of whom 1108 completed the questionnaire. While 86.1% of rheumatologists estimated using T2T principles in clinical practice, only 66.6% of patients were reported by their physician to be managed using a T2T approach. Achieving disease remission was the most commonly reported treatment goal identified by rheumatologists (79.7%), followed by symptom control (47.8%) and reducing impact on quality of life (44.5%). 40.8% of rheumatologists and their patients were in agreement that a treatment goal had been set. When there was agreement on treatment goals, we observed better patient satisfaction, engagement and treatment success.Conclusions Despite recommendations, the T2T approach in RA appears to be suboptimally implemented in clinical practice. This highlights the importance of patient-centricity in the decision-making process to define meaningful targets and select appropriate treatments to improve disease outcomes.https://rmdopen.bmj.com/content/8/2/e002658.full
spellingShingle Bruno Fautrel
Rieke Alten
Yves Piette
Roberto Caporali
Susana Romero-Yuste
Jasper Broen
Katrien Van Beneden
Martin Welcker
Peter C. Taylor
Oliver Howell
Elke Rottier
Monia Zignani
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
RMD Open
title Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
title_full Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
title_fullStr Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
title_full_unstemmed Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
title_short Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
title_sort treat to target in rheumatoid arthritis a real world study of the application and impact of treat to target within the wider context of patient management patient centricity and advanced therapy use in europe
url https://rmdopen.bmj.com/content/8/2/e002658.full
work_keys_str_mv AT brunofautrel treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT riekealten treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT yvespiette treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT robertocaporali treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT susanaromeroyuste treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT jasperbroen treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT katrienvanbeneden treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT martinwelcker treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT peterctaylor treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT oliverhowell treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT elkerottier treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope
AT moniazignani treattotargetinrheumatoidarthritisarealworldstudyoftheapplicationandimpactoftreattotargetwithinthewidercontextofpatientmanagementpatientcentricityandadvancedtherapyuseineurope